# Thomas King

Thomas King of Brooklyn, NY appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. 8 filing roles across Form D (7), Form ADV (1).

## Filings (8)

| Filed | Source | Entity | Role | Location |
| --- | --- | --- | --- | --- |
| 2026-01-30 | Form ADV | [SARVER VROOMAN WEALTH ADVISORS LLC](https://search.stillhousedata.com/firm/332699) | PARTNER | KANSAS CITY, MO |
| 2009-03-24 | Form D | [THERMASOURCE LLC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1440592&type=&dateb=&owner=include&count=40) | Director | SANTA ROSA, CA |
| 2016-10-26 | Form D | [EVOWORX INC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1457134&type=&dateb=&owner=include&count=40) | Director | SEATTLE, WA |
| 2019-09-12 | Form D | [Faraday Pharmaceuticals, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1614107&type=&dateb=&owner=include&count=40) | Director | SEATTLE, WA |
| 2018-11-13 | Form D | [Concentric Analgesics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1682398&type=&dateb=&owner=include&count=40) | Director | SAN FRANCISCO, CA |
| 2018-02-12 | Form D | [Satsuma Pharmaceuticals, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1692830&type=&dateb=&owner=include&count=40) | Director | South San Francisco, CA |
| 2025-10-09 | Form D | [Limivorous Preferred Fund LP](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1731959&type=&dateb=&owner=include&count=40) | Executive Officer | BROOKLYN, NY |
| 2024-09-13 | Form D | [Black Ice Data Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2037268&type=&dateb=&owner=include&count=40) | Director | MERIDIAN, ID |


---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.